How difficult and expensive would it be for RAC to commission the authors of that diabetes 2 research to replicate their findings and expand on that research?
Pre-clinical research is cheap, and those researchers are well set up to do follow-on research.
RAC is not limited to just doing pre-clinical work in Wollongong and Newcastle universities….they can commission work
from all over the world….they have the money in the bank and academic researchers are always desperate for research funds.
….
the Diabetes 2 treatment field is enormous!
Agile is the key word!
- Forums
- ASX - By Stock
- RAC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-35
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.000(0.00%) |
Mkt cap ! $257.4M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.45 | $189.2K | 127.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 648 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 648 | 1.505 |
1 | 648 | 1.490 |
1 | 5338 | 1.475 |
1 | 10000 | 1.470 |
1 | 2000 | 1.445 |
Price($) | Vol. | No. |
---|---|---|
1.545 | 300 | 1 |
1.550 | 8484 | 3 |
1.560 | 1982 | 1 |
1.565 | 5000 | 1 |
1.580 | 10451 | 1 |
Last trade - 12.30pm 21/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online